• Make it like cafepharma, but for different industries: over the years we’ve had suggestions for creating a site similar to cafepharma, but for different industries. Now there is a place. Check out CompanyUnderground for company forums in other industries. Don’t see a company? Request it here. Let your friends and family outside the pharma/medical sales space know they now have a safe, anonymous place to talk.


Cadence will be hiring soon

Quote






Are you an idiot? Why would you assume any of us would just go take any other job? If you want to be stupid and rest everything on this company, that is your business. Most will take a smarter approach and look at other great opportunities. Do you think this is the only game in town? Give me a break. There are a lot of great opportunities out there if you are a strong candidate. Many of the prospects that I know that were going for Cadence have now moved onto other great opportunities - that also include GREAT benefits. You are talking out of both sides of your mouth because then you bring up unemployment rates - so you are suggesting that people just wait it out and hope the Cadence opportunity comes through? Look, anyone that is smart is looking very aggressively now to find a job - clearly there are even greater opportunities out there than just Cadence. I know of 2 people myself that have gone onboard elsewhere due to this delay and they ended up getting even better opportunities. If there are no other alternatives - then yes, take the Cadence job. However, everyone needs to look at the entire package versus looking at just base pay - in the end Cadence's "benefits" might end up putting you in the red compared to other opportunities.


Anonymous said:
First of all, who says that I am putting all of my eggs in one basket. Yes, I believe it is wise to keep looking for other opportunities in a time such as this, but get real. This whole thing is about everyone complaining about the benefits, the car package, etc. Are you serious? Have you seen the nation's unemployment rates? When this comes through, the reps will be paid at the top 3% of the entire country, so stop your whining and go find another fantastic job with all of those other opportunities that await you. The investors don't know any more and probably even less than the upper management at Cadence what is going to happen. Maybe it will be a while, but so what? If you really hate what they are offering you...disappear. I say, either wait it out and be happy when it happens, of go away and find another job. It there is so much awaiting you out there, then why are you wasting all of your time moaning on this board?
Click to expand...
 






Anonymous said:
Are you an idiot? Why would you assume any of us would just go take any other job? If you want to be stupid and rest everything on this company, that is your business. Most will take a smarter approach and look at other great opportunities. Do you think this is the only game in town? Give me a break. There are a lot of great opportunities out there if you are a strong candidate. Many of the prospects that I know that were going for Cadence have now moved onto other great opportunities - that also include GREAT benefits. You are talking out of both sides of your mouth because then you bring up unemployment rates - so you are suggesting that people just wait it out and hope the Cadence opportunity comes through? Look, anyone that is smart is looking very aggressively now to find a job - clearly there are even greater opportunities out there than just Cadence. I know of 2 people myself that have gone onboard elsewhere due to this delay and they ended up getting even better opportunities. If there are no other alternatives - then yes, take the Cadence job. However, everyone needs to look at the entire package versus looking at just base pay - in the end Cadence's "benefits" might end up putting you in the red compared to other opportunities.
Click to expand...

the base pay isn't all that either. just a couple thousand more than what i'm making, so no big jump by a long shot
 






Anonymous said:
Are you an idiot? Why would you assume any of us would just go take any other job? If you want to be stupid and rest everything on this company, that is your business. Most will take a smarter approach and look at other great opportunities. Do you think this is the only game in town? Give me a break. There are a lot of great opportunities out there if you are a strong candidate. Many of the prospects that I know that were going for Cadence have now moved onto other great opportunities - that also include GREAT benefits. You are talking out of both sides of your mouth because then you bring up unemployment rates - so you are suggesting that people just wait it out and hope the Cadence opportunity comes through? Look, anyone that is smart is looking very aggressively now to find a job - clearly there are even greater opportunities out there than just Cadence. I know of 2 people myself that have gone onboard elsewhere due to this delay and they ended up getting even better opportunities. If there are no other alternatives - then yes, take the Cadence job. However, everyone needs to look at the entire package versus looking at just base pay - in the end Cadence's "benefits" might end up putting you in the red compared to other opportunities.
Click to expand...

I agree with this statement. When I sat down and did my own financial comparison with all the benefits, this opportunity wasn't all that great. Having a company car versus getting your own vehicle is a huge cost difference in of itself. I can't believe they have specifics on what you can buy and what you can't. Making sure you have an adequate car is one thing, but anything beyond that is ridiculous. I will take the job if nothing else comes through, but I am also looking.
 






























Anonymous said:
When this drug finally does launch, is anyone going to try to renegotiate their original offer?
Click to expand...

More than likely that will have to enhance their benefit package and perhaps go with company vehicles as many representatives went on to other opportunities and will have to entice them to come back to Cadence.
 






Anonymous said:
More than likely that will have to enhance their benefit package and perhaps go with company vehicles as many representatives went on to other opportunities and will have to entice them to come back to Cadence.
Click to expand...

Uh no...there are back-up reps for just about every territory, so they won't need to do anything. There are actually people out there who are happy with their offer.
 






Anonymous said:
When this drug finally does launch, is anyone going to try to renegotiate their original offer?
Click to expand...

I've been thinking about this, too. It's been almost 8 months, most people received 5% annual increases if they have been employed during this time. On the other hand, I know a lot of people are out of work right now. Tough call. Although I doubt Cadence is in the position to offer anything more right now.
 












Anonymous said:
Uh no...there are back-up reps for just about every territory, so they won't need to do anything. There are actually people out there who are happy with their offer.
Click to expand...

I agree -this is obviously some internal dumb manager making a stupid comment. They better hope all the good candidates decide to continue forward. Many were on the fence because of the lack of good benefits and deep down they know that. tep it up Cadence and offer some good benefits!
 


















Anonymous said:
Silence is not a good sign. I will keep my fingers crossed for Monday. I can't hold on any longer than that.
Click to expand...

I have not heard anything either. But, I did see this.


UPDATE 1-Oppenheimer cuts Cadence to underperform
9:44AM ET on Friday Apr 16, 2010 via Thomson Reuters
* Says Ofirmev manufacturing raises concerns

* Says Cadence need for cash will weigh on share prices

April 16 (Reuters) - Oppenheimer & Co Inc downgraded drug developer Cadence Pharmaceuticals Inc <CADX.O> to "underperform" from "perform" on manufacturing concerns over its experimental intravenous painkiller Ofirmev.

Manufacturing issues regarding the drug could lead to a delay in resubmission of its marketing application by third-party manufacturer Baxter <BAX.N> and potentially prevent its launch until late 2011, the brokerage said in a note to clients.

The U.S. health regulator declined to approve the drug in February citing deficiencies in its manufacturing facility. <ReutersLink ID='ID:nSGE61A0IA' />

Oppenheimer said following the outcome of a meeting between the U.S. Food and Drug Administration (FDA) and Baxter, there could be a large sell-off of Cadence shares if the agency asks for additional stability and validation batches.

Baxter is scheduled to meet the FDA on Friday.

The brokerage said the company's need for additional cash in 2010 might further pressure the share price.

It expects the company to raise about $100 million during the third quarter.

Additionally, "Hospira Inc's <HSP.N> recent offer to acquire Javelin Pharmaceuticals may suggest that Hospira favored Javelin's suite of products for acute and post-operative pain over Cadence's Ofirmev," the brokerage said.

Shares of Cadence were trading down 4 percent at $9 on Nasdaq. (Reporting by Krishnakali Sengupta in Bangalore; Editing by Roshni Menon)
.
 






Thank you so much for sharing this. Unfortunately, the signs all seem to be there...At minimum, this probably won't happen until 2011 so not a good option for now. Equally just as important, I would be willing to bet they lay off the area managers. They have been on salary for a year now and I can't imagine Cadence being able to afford to keep them on the payroll.


Anonymous said:
I have not heard anything either. But, I did see this.


UPDATE 1-Oppenheimer cuts Cadence to underperform
9:44AM ET on Friday Apr 16, 2010 via Thomson Reuters
* Says Ofirmev manufacturing raises concerns

* Says Cadence need for cash will weigh on share prices

April 16 (Reuters) - Oppenheimer & Co Inc downgraded drug developer Cadence Pharmaceuticals Inc <CADX.O> to "underperform" from "perform" on manufacturing concerns over its experimental intravenous painkiller Ofirmev.

Manufacturing issues regarding the drug could lead to a delay in resubmission of its marketing application by third-party manufacturer Baxter <BAX.N> and potentially prevent its launch until late 2011, the brokerage said in a note to clients.

The U.S. health regulator declined to approve the drug in February citing deficiencies in its manufacturing facility. <ReutersLink ID='ID:nSGE61A0IA' />

Oppenheimer said following the outcome of a meeting between the U.S. Food and Drug Administration (FDA) and Baxter, there could be a large sell-off of Cadence shares if the agency asks for additional stability and validation batches.

Baxter is scheduled to meet the FDA on Friday.

The brokerage said the company's need for additional cash in 2010 might further pressure the share price.

It expects the company to raise about $100 million during the third quarter.

Additionally, "Hospira Inc's <HSP.N> recent offer to acquire Javelin Pharmaceuticals may suggest that Hospira favored Javelin's suite of products for acute and post-operative pain over Cadence's Ofirmev," the brokerage said.

Shares of Cadence were trading down 4 percent at $9 on Nasdaq. (Reporting by Krishnakali Sengupta in Bangalore; Editing by Roshni Menon)
.
Click to expand...
 
























Top Bottom
Back
Quote